News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Stephen Casey

Advertisement

Articles by Stephen Casey

Stephen Casey

From Science to Sales: Leveraging Medical Affairs for Commercial Triumph

ByStephen Casey
April 15th 2025

Marketing and sales personnel who leverage the expertise and insights of MedAffairs can often have better success.

Advertisement

Latest Updated Articles

  • Stephen Casey
    From Science to Sales: Leveraging Medical Affairs for Commercial Triumph

    April 15th 2025



Advertisement
Advertisement

Trending on PharmExec

1

How a Shifting Landscape is Making Affordable DTP At Scale a Reality

2

The Death of Deciling

3

BioNTech Releases First Quarter Results for 2026

4

Asembia ASX26: How Payers are Embracing Value-Based Care Models for Cell & Gene Therapies

5

UCB Enters $2.2 Billion Agreement to Acquire Candid Therapeutics

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us